Probest Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 01-07-2024
- Paid Up Capital ₹ 0.10 M
as on 01-07-2024
- Company Age 22 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.70 M
as on 01-07-2024
- Revenue 2.13%
(FY 2020)
- Profit -69.22%
(FY 2020)
- Ebitda -13.30%
(FY 2020)
- Net Worth 3.88%
(FY 2020)
- Total Assets 6.36%
(FY 2020)
About Probest Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.70 M.
Narendra Singh and Manpreet Khurana serve as directors at the Company.
- CIN/LLPIN
U24239DL2002PTC114413
- Company No.
114413
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Probest Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Singh  | Director | 22-Feb-2008 | Current |
| Manpreet Khurana | Director | 28-Feb-2002 | Current |
Financial Performance of Probest Pharma.
Probest Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.13% increase. The company also saw a substantial fall in profitability, with a 69.22% decrease in profit. The company's net worth moved up by a moderate rise of 3.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Probest Pharma?
In 2020, Probest Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gga Kingclub Business Consultancy And Entertainment Private LimitedActive 3 years 1 monthNarendra Singh and Manpreet Khurana are mutual person
- Sikok Business Consultancy And Entertainment Services Private LimitedActive 3 years 1 month
Narendra Singh and Manpreet Khurana are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab & Sind Bank Creation Date: 07 Aug 2008 | ₹0.70 M | Open |
How Many Employees Work at Probest Pharma?
Unlock and access historical data on people associated with Probest Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Probest Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Probest Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
